Alpha lipoic acid (ALA) is safe for most adults at typical supplement doses. Clinical trials have used doses ranging from 600 to 1,800 mg per day for months at a time without serious adverse effects, and a four-year observational study found that daily use across multiple dosages was well tolerated. That said, a few specific situations raise the risk profile enough to be worth understanding before you start taking it.
What Doses Have Been Studied
Most supplements on the market contain between 50 and 600 mg per capsule, which is already up to 1,000 times more than you’d get from food alone. In clinical trials focused on diabetic nerve pain, 600 mg per day was as effective as 1,200 or 1,800 mg per day, making it the practical ceiling for most people looking for benefits without unnecessary excess.
Higher doses have still shown acceptable safety. Oral doses of 1,800 mg per day for six months and 1,200 mg per day for two years did not cause serious adverse effects in studies of people with diabetic neuropathy. A pilot study in people with multiple sclerosis found that 2,400 mg per day for two weeks was generally well tolerated. These were supervised clinical settings, though, not casual supplementation.
Common Side Effects
The side effects that do show up tend to be mild. A four-year study tracking people on daily ALA at doses between 400 and 1,200 mg recorded nausea, vomiting, dizziness, skin rash, low blood sugar, and low blood pressure as the main complaints. No serious adverse events were recorded across any dosage group, and the rates of these mild effects didn’t differ meaningfully between lower and higher doses.
Gastrointestinal symptoms, particularly nausea, are the most commonly reported issue. Taking ALA with food can help, though absorption is better on an empty stomach. If stomach upset is a problem, starting at a lower dose and gradually increasing may reduce discomfort.
Blood Sugar and Hypoglycemia Risk
ALA improves insulin sensitivity. A study of 72 people with type 2 diabetes found that 600 mg per day improved insulin sensitivity by 25% after four weeks. That’s a meaningful shift, and it means ALA can genuinely lower blood sugar levels, not just on paper but enough to matter.
For most people, this is a benefit. But if you already take medication that lowers blood sugar, stacking ALA on top could push your levels too low. Symptoms of hypoglycemia include shakiness, sweating, confusion, and feeling faint. If you use insulin or other glucose-lowering drugs, monitoring your blood sugar more closely when starting ALA is a practical precaution.
There’s also a rarer concern. Health Canada completed a safety review and concluded that ALA can trigger a condition called insulin autoimmune syndrome (IAS) in people with a specific genetic variation. This causes the body to produce antibodies against its own insulin, leading to episodes of dangerously low blood sugar. Most reported cases have occurred in people of Asian descent, where the genetic variation is more common, though cases have appeared in Europe as well. The condition resolved in every case once ALA was stopped. This is rare, but worth knowing about, especially if you experience unexplained hypoglycemia symptoms after starting the supplement.
Interactions With Cancer Treatment
ALA is a potent antioxidant, and that property creates a specific concern during cancer treatment. Both chemotherapy and radiation therapy work in part by generating reactive molecules that damage cancer cells. An antioxidant that neutralizes those molecules could, in theory, reduce the effectiveness of treatment. Memorial Sloan Kettering Cancer Center notes that ALA may antagonize the effects of chemotherapy and radiation for exactly this reason.
This doesn’t mean ALA causes harm on its own in the context of cancer. It means taking it alongside active treatment could work against the treatment itself. If you’re undergoing or about to start chemotherapy or radiation, this is a conversation to have with your oncologist before continuing ALA.
Long-Term Safety
One of the more reassuring pieces of evidence comes from a retrospective study that followed healthy adults taking ALA daily for four years. The study tested four different formulations and dosages (400, 600, 800, and 1,200 mg). No serious adverse events were recorded across any group. The mild side effects that appeared, like occasional nausea or dizziness, didn’t increase with longer use or higher doses.
The same study found that higher doses improved blood sugar markers and cholesterol profiles over time, while lower doses did not produce those metabolic benefits. So there’s a practical tradeoff: lower doses are equally safe but may not deliver the effects you’re looking for, while 600 mg and above appears to be where both benefits and mild side effects become more noticeable.
Who Should Be Cautious
- People taking diabetes medications: ALA’s blood sugar lowering effect can compound with insulin or oral glucose-lowering drugs, raising the risk of hypoglycemia.
- People undergoing cancer treatment: ALA’s antioxidant activity may interfere with the mechanisms of chemotherapy and radiation.
- People with a history of unexplained low blood sugar: The rare risk of insulin autoimmune syndrome means unexplained hypoglycemic episodes after starting ALA should be taken seriously.
- Pregnant or breastfeeding women: There is limited safety data in these populations, so the risk-benefit picture is unclear.
For the average adult taking a standard 300 to 600 mg dose, the safety record over both short and multi-year use is solid. The supplement has been studied in clinical trials more rigorously than many others on the market, and the consistent finding is that serious harm is uncommon. The main practical risks come from its real biological effects, particularly on blood sugar, which are predictable and manageable when you know to watch for them.